Package 68071-1971-6

{"route": ["ORAL"], "spl_id": "3ab5a044-1530-14af-e063-6394a90a35ca", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0368071197198"], "unii": ["0H73WJJ391"], "rxcui": ["199888"], "spl_set_id": ["490f109f-30cb-0790-e054-00144ff88e88"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["NuCare Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (68071-1971-3)", "package_ndc": "68071-1971-3", "marketing_start_date": "20170221"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (68071-1971-6)", "package_ndc": "68071-1971-6", "marketing_start_date": "20170221"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (68071-1971-9)", "package_ndc": "68071-1971-9", "marketing_start_date": "20170221"}], "brand_name": "Topiramate", "product_id": "68071-1971_3ab5a044-1530-14af-e063-6394a90a35ca", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68071-1971", "generic_name": "Topiramate", "labeler_name": "NuCare Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "25 mg/1"}], "application_number": "ANDA076343", "marketing_category": "ANDA", "marketing_start_date": "20140612", "listing_expiration_date": "20261231"}